Sign in

CIK 0001484612

  • Accelerated filer
  • Smaller reporting company

Outset Medical, Inc.

Sign in to watch
Ticker
OM
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
200514392
Phone
+1 669-231-8200
Business address
3052 ORCHARD DRIVE, SAN JOSE, CA, 95134
Former names
Home Dialysis Plus, Ltd.
  1. 4 Option exercise Director acquired 250,000 shares (option exercise)
  2. 4 Option exercise Director acquired 31,250 shares (option exercise)
  3. 4 Option exercise Director acquired 187,500 shares (option exercise)
  4. 4 Option exercise Director acquired 3,125,000 shares (option exercise)
  5. 4 Open-market sale Chair and CEO sold 14,611 shares at $0.90 ($13,150)
  6. 4 Open-market sale SVP Operations and R&D sold 4,204 shares at $0.90 ($3,784)
  7. 4 Open-market sale General Counsel sold 6,145 shares at $0.90 ($5,531)
  8. 4 Open-market sale Chief Financial Officer sold 8,659 shares at $0.90 ($7,793)
  9. 4 Open-market sale Chair and CEO sold 65,236 shares at $0.80 ($52,189)
  10. 4 Open-market sale SVP Operations and R&D sold 23,221 shares at $0.80 ($18,577)
  11. 4 Open-market sale General Counsel sold 32,930 shares at $0.80 ($26,344)
  12. 4 Open-market sale Chief Financial Officer sold 34,288 shares at $0.80 ($27,430)
  13. 4 Open-market sale Chair and CEO sold 33,227 shares at $0.81 ($26,914)
  14. 4 Open-market sale SVP Operations and R&D sold 15,011 shares at $0.81 ($12,159)
  15. 4 Open-market sale General Counsel sold 20,492 shares at $0.81 ($16,599)
  16. 4 Open-market sale Chief Financial Officer sold 29,031 shares at $0.81 ($23,515)
  17. 4 Open-market sale Chair and CEO sold 10,227 shares at $1.29 ($13,193)
  18. 4 Open-market sale SVP Operations and R&D sold 720 shares at $1.29 ($929)
  19. 4 Open-market sale General Counsel sold 1,572 shares at $1.29 ($2,028)
  20. 4 Open-market sale Chief Financial Officer sold 1,835 shares at $1.29 ($2,367)

Page 4 of 19 · 379 filings